Lymph node surgery for early-stage ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies whether removing (dissecting) lymph nodes during surgery can improve care for people with early-stage ovarian cancer that still needs chemotherapy. You may be eligible if you have certain ovarian cancer types and your scans and surgery do not show clearly suspicious lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and can sign consent.
- You have epithelial ovarian cancer that is FIGO stage IA to IIA, with a plan for adjuvant (after-surgery) chemotherapy.
- Your cancer type fits certain categories (like high-grade serous or clear cell, among others).
- Your usual walking/health ability is good (ECOG 0 or 1).
- Your scans and the planned surgery do not already show suspicious, enlarged lymph nodes.
- You have not had prior ovarian chemotherapy or prior abdominal/pelvic radiation, and you have not had lymph node surgery before in the retroperitoneal area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether removing enlarged lymph nodes near the heart and lungs during surgery for advanced ovarian cancer can help you live longer and feel better. You must have already had surgery to remove most of your tumor and have specific lymph node changes on imaging.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This trial studies whether removing lymph nodes in the upper abdomen (hepatoceliac lymph nodes) improves outcomes for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer that has spread to those lymph nodes. It also looks at how this surgery works for people with certain types of relapse, often alongside chemotherapy.
This trial tests a new way to look at lymph nodes during surgery for gynecologic cancers. It may help doctors decide immediately if cancer has spread to the lymph nodes, which could guide treatment decisions during the same operation.
This study tests a technique to find and remove only the lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It uses a special dye to highlight the sentinel lymph nodes, which may reduce side effects while still checking for spread.
This trial studies whether removing lymph nodes during surgery helps people with stage IIICr cervical cancer. It looks at outcomes and may help guide better treatment for lymph node spread.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.